AripiprazoleIn Major Depressive Disorder

被引：0
作者：
Juliane Weber
Katherine A. Lyseng-Williamson
Lesley J. Scott
机构：
[1] Wolters Kluwer Health ∣ Adis,
[2] Wolters Kluwer Health,undefined
来源：
CNS Drugs | 2008年 / 22卷
关键词：
Major Depressive Disorder; Major Depressive Disorder; Aripiprazole; Montgomery Asberg Depression Rate Scale; Atypical Antipsychotic Agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▴ Aripiprazole, an oral quinolinone, is the first atypical antipsychotic agent to be approved in the US as adjunctive treatment in adult patients with major depressive disorder (MDD).
引用
收藏
页码：807 / 813
页数：6
相关论文
共 43 条
[1]  
Montgomery SA(2008)The under-recognized role of dopamine in the treatment of major depressive disorder Int Clin Psychopharmacol 23 63-9
[2]  
Keller MB(2005)Issues in treatment-resistant depression J Clin Psychiatry 66 5-12
[3]  
Nierenberg AA(2007)A critical overview of the pharmacologic management of treatment-resistant depression Psychiatr Clin North Am 30 13-29
[4]  
Katz J(2006)Treatment-resistant de-pression J Clin Psychiatry 6 16-22
[5]  
Fava M(2008)Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder Acta Psychiatr Scand 117 253-9
[6]  
Souery D(2008)Augmentation of antidepressants with atypical antipsychotics: a review of the current literature J Psychiatr Pract 14 34-44
[7]  
Papakostas GI(2008)Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence CNS Drugs 22 367-88
[8]  
Trivedi MH(2004)Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder Drugs 64 1715-36
[9]  
Shelton RC(2008)Intramuscular aripiprazole: a review of its use in the management of agitation in schizophrenia and bipolar I disorder CNS Drugs 22 335-52
[10]  
Papakostas GI(2002)The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT Eur J Pharmacol 441 137-40
12345